PolyPeptide Group AG (SWX:PPGN)
Switzerland · Delayed Price · Currency is CHF 43.95
0.00 (0.00%)
Aug 21, 2026, 5:31 PM CET
PolyPeptide Group AG Market Cap
PolyPeptide Group AG has a market cap or net worth of 1.45 billion as of August 21, 2026. Its market cap has increased by 52.45% in one year.
Market Cap
1.45B
Enterprise Value
1.53B
Revenue
423.58M
Ranking
n/a
PE Ratio
107.48
Stock Price
43.95
ChartMarket Cap Chart
Since April 29, 2021, PolyPeptide Group AG's market cap has decreased from 2.59B to 1.45B, a decrease of -43.98%. That is a compound annual growth rate of -10.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 1.45B | 68.52% |
| Dec 30, 2025 | 861.08M | -8.08% |
| Dec 30, 2024 | 936.73M | 62.30% |
| Dec 29, 2023 | 577.18M | -30.79% |
| Dec 30, 2022 | 833.98M | -81.57% |
| Dec 30, 2021 | 4.53B | 74.70% |
| Apr 29, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 299.69B |
| Novartis AG | 242.19B |
| Lonza Group AG | 41.36B |
| Galderma Group AG | 40.00B |
| Medacta Group | 2.57B |
| Tecan Group AG | 2.35B |
| SKAN Group AG | 1.47B |
| Idorsia | 1.46B |